1.
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
by Denkert, Carsten
The lancet oncology, 2018-01, Vol.19 (1), p.40-50

2.
Nomograms in oncology: more than meets the eye
by Balachandran, Vinod P, Dr
The lancet oncology, 2015, Vol.16 (4), p.e173-e180

3.
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
by Cortes, Jorge E
The lancet oncology, 2019-07, Vol.20 (7), p.984-997

4.
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
by Rajkumar, S Vincent, Prof
The lancet oncology, 2014, Vol.15 (12), p.e538-e548

5.
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data
by Anon
The lancet oncology, 2016, Vol.17 (6), p.779-790

6.
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analys...
by Franko, Jan, Dr
The lancet oncology, 2016, Vol.17 (12), p.1709-1719

7.
Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer
by Sun, Ming
Tumor biology, 2013-09-05, Vol.35 (2), p.1065-1073

8.
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
by Choueiri, Toni K, Dr
The lancet oncology, 2016, Vol.17 (7), p.917-927

9.
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
by Stilgenbauer, Stephan, Prof
The lancet oncology, 2016, Vol.17 (6), p.768-778

10.
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
by Sharma, Padmanee, Prof
The lancet oncology, 2017, Vol.18 (3), p.312-322

11.
Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sa...
by Callegaro, Dario, MD
The lancet oncology, 2016, Vol.17 (5), p.671-680

12.
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
by Tawbi, Hussein A
The lancet oncology, 2017-11, Vol.18 (11), p.1493-1501

13.
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multi...
by O'Sullivan, Brian, Prof
The lancet oncology, 2016, Vol.17 (4), p.440-451

14.
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-...
by Nywening, Timothy M, MD
The lancet oncology, 2016, Vol.17 (5), p.651-662

15.
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
by Younes, Anas, Prof
The lancet oncology, 2016, Vol.17 (9), p.1283-1294

16.
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial
by Erlandsson, Johan, Dr
The lancet oncology, 2017, Vol.18 (3), p.336-346

17.
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma
by Erstad, Derek J
Annals of surgical oncology, 2019-02-20, Vol.26 (5), p.1474-1493

18.
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinic...
by Pastore, Alessandro, MD
The lancet oncology, 2015, Vol.16 (9), p.1111-1122

19.
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma
by Lopci, Egesta
European journal of nuclear medicine and molecular imaging, 2017-01-21, Vol.44 (7), p.1155-1164

20.
Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review
by Mierzynska, Justyna
The lancet oncology, 2019-12, Vol.20 (12), p.e685-e698
